Coronary heart disease together with sudden cardiac death is now the main cause of death in patients being treated for hypertension at the Wellcome Medical Research Institute, probably because of areduction in deaths from heart failure and stroke. A hypotensive agent with antiarrhythmic properties might, therefore, be valuable. This work confirms the hypotensive action of the antiarrhythmic agent propranolol in hypertensive patients. In subiects with mild to moderate hypertension, propranolol controlled the hypertension adequately in 30 to 40 per cent. The dose was higher than that necessary for antiarrhythmic effects. The hypotensive effect of propranolol was fully estahlished after one day; no cumulation but rather mild tolerance developed. Hendrika J. Waal, B.Med.Sc., M.B., eh.B. IN.ZJ